Company: GRCE
Filing Date: 2025-03-10
Form Type: S-3
Source: 0001140361-25-007769
Chunk: 31

Company: Grace Therapeutics, Inc.
Filing Date: 2025-03-10
Form: S-3
Chunk 31
---
 Consent of Hogan Lovells US LLP (included in Exhibit 5.1)                                        |
| 24.1*   |     | Power of attorney (included on Signature Page)                                                   |
| 107*    |     | Filing Fee Table                                                                                 |

| * | Filed herewith. |

| Item 17. | Undertakings. |

The undersigned Registrant hereby undertakes:

| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |

| (i) | To include any prospectus required by Section 10(a)(3) of the Securities Act; |

| (ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most                                                                                                                   
 recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume 
 of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of          
 prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” or 
 “Calculation of Registration Fee” table, as applicable, in the effective registration statement; and (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement 
 or any material change to such information in the registration statement; provided, however, that paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if the information required to be included in a post-effective amendment by those 
 paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act, that are incorporated by reference in the registration statement, or is contained  
 in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.                                                                                                                                              |

| (2) | That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed                                                               
 to be a new registration statement relating to the securities offered therein